Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 156601-156650 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT02290665
Localized Therapeutics for the Treatment of Gastrointestinal Disorders
NA
Completed
18 participants
Started: Jan 30, 2015 · Completed: Sep 28, 2015
1 condition
1 sponsor
1 location
NCT02357420
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
PHASE2
Completed
393 participants
Started: Jan 29, 2015 · Completed: Jun 9, 2016
3 conditions
1 sponsor
98 locations
NCT02171897
Pertrochanter Arthroplasty Versus Osteosynthesis
NA
Completed
70 participants
Started: Jan 29, 2015 · Completed: Oct 21, 2018
1 condition
1 sponsor
1 location
NCT02349867
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer
PHASE1
Completed
23 participants
Started: Jan 29, 2015 · Completed: May 13, 2022
7 conditions
2 sponsors
1 location
NCT03388892
Drug-Eluting Balloon in Arteriovenous Graft
NA
Completed
44 participants
Started: Jan 29, 2015 · Completed: Nov 20, 2018
3 conditions
1 sponsor
1 location
NCT02166021
Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis
PHASE2
Completed
48 participants
Started: Jan 29, 2015 · Completed: Dec 24, 2018
1 condition
1 sponsor
1 location
NCT02291003
Identification of Novel Circadian Biomarkers
N/A
Completed
3 participants
Started: Jan 29, 2015 · Completed: Sep 30, 2017
1 condition
1 sponsor
1 location
NCT02858401
Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults
PHASE1
Completed
48 participants
Started: Jan 29, 2015 · Completed: Feb 14, 2019
1 condition
1 sponsor
8 locations
NCT02467335
Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects
PHASE1
Completed
52 participants
Started: Jan 29, 2015 · Completed: Oct 3, 2015
1 condition
2 sponsors
1 location
NCT03725644
Parent Training Program for Preschool Children With Autism Spectrum Disorders
NA
Completed
40 participants
Started: Jan 29, 2015 · Completed: Sep 30, 2017
1 condition
1 sponsor
0 locations
NCT02324907
The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis
N/A
Completed
39 participants
Started: Jan 28, 2015 · Completed: Jan 9, 2023
1 condition
2 sponsors
1 location
NCT02422043
Description of Socio-cognitive and Clinic Changes for Type 1 Diabetes Adolescents Cohort With Therapeutic Patient Education Program
NA
Completed
34 participants
Started: Jan 28, 2015 · Completed: Nov 15, 2022
1 condition
1 sponsor
1 location
NCT03013322
Anticholium® Per Se
NA
Completed
20 participants
Started: Jan 28, 2015 · Completed: Feb 18, 2017
3 conditions
1 sponsor
1 location
NCT02349789
The Role of Cerebellar Hyperactivity in Parkinson's Disease
N/A
Completed
11 participants
Started: Jan 28, 2015 · Completed: Sep 30, 2017
1 condition
3 sponsors
1 location
NCT02495389
Mirabegron and Urinary Urgency Incontinence
PHASE4
Completed
84 participants
Started: Jan 28, 2015 · Completed: Jan 29, 2019
1 condition
2 sponsors
1 location
NCT02357901
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
PHASE3
Completed
665 participants
Started: Jan 28, 2015 · Completed: Apr 29, 2016
2 conditions
1 sponsor
38 locations
NCT02347787
A Multi-center Trial of IMPaCT CHW Support for Chronically-ill Patients
NA
Completed
592 participants
Started: Jan 28, 2015 · Completed: Jul 31, 2018
4 conditions
2 sponsors
0 locations
NCT02315586
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
N/A
Completed
63 participants
Started: Jan 28, 2015 · Completed: Feb 23, 2022
1 condition
1 sponsor
1 location
NCT03256552
Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD
PHASE2
Completed
66 participants
Started: Jan 28, 2015 · Completed: Sep 5, 2015
1 condition
1 sponsor
18 locations
NCT02170246
Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
PHASE1
Completed
21 participants
Started: Jan 28, 2015 · Completed: Jun 13, 2018
2 conditions
7 sponsors
2 locations
NCT02332720
Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
PHASE2
Completed
413 participants
Started: Jan 28, 2015 · Completed: May 3, 2017
1 condition
1 sponsor
0 locations
NCT02251990
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)
PHASE3
Completed
489 participants
Started: Jan 28, 2015 · Completed: Apr 10, 2017
1 condition
1 sponsor
0 locations
NCT02332590
Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
PHASE3
Completed
369 participants
Started: Jan 28, 2015 · Completed: Dec 29, 2020
1 condition
2 sponsors
86 locations
NCT02073097
Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma
PHASE1/PHASE2
Completed
48 participants
Started: Jan 28, 2015 · Completed: Jun 29, 2023
5 conditions
1 sponsor
3 locations
NCT01740557
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma
PHASE1/PHASE2
Completed
10 participants
Started: Jan 28, 2015 · Completed: Apr 21, 2023
3 conditions
2 sponsors
1 location
NCT02361788
Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)
N/A
Completed
1,710 participants
Started: Jan 28, 2015 · Completed: May 18, 2019
1 condition
1 sponsor
1 location
NCT02185781
Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
PHASE1
Completed
6 participants
Started: Jan 28, 2015 · Completed: Nov 29, 2021
3 conditions
1 sponsor
6 locations
NCT02461771
Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
PHASE1
Completed
13 participants
Started: Jan 28, 2015 · Completed: Mar 8, 2016
1 condition
1 sponsor
4 locations
NCT03235830
Text Messaging in Healthcare Utilization
NA
Completed
231 participants
Started: Jan 28, 2015 · Completed: Aug 5, 2016
1 condition
1 sponsor
0 locations
NCT02375477
Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods
NA
Completed
38 participants
Started: Jan 27, 2015 · Completed: Jan 6, 2018
2 conditions
2 sponsors
1 location
NCT03516825
Musical Neglect Training for Patients With Visual Neglect
NA
Completed
2 participants
Started: Jan 27, 2015 · Completed: Jan 28, 2016
1 condition
2 sponsors
0 locations
NCT02415712
Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)
N/A
Completed
147 participants
Started: Jan 27, 2015 · Completed: Jun 30, 2022
1 condition
1 sponsor
2 locations
NCT02337738
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants
PHASE2/PHASE3
Completed
404 participants
Started: Jan 27, 2015 · Completed: Sep 17, 2016
1 condition
1 sponsor
57 locations
NCT04955028
MRI in Predicting Intraoperative Massive Hemorrhage for Cesarean Scar Pregnancy
N/A
Completed
300 participants
Started: Jan 27, 2015 · Completed: Jul 1, 2019
1 condition
1 sponsor
0 locations
NCT02354404
Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
PHASE1
Completed
90 participants
Started: Jan 27, 2015 · Completed: Apr 19, 2017
1 condition
3 sponsors
1 location
NCT02320305
MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery
EARLY_PHASE1
Completed
23 participants
Started: Jan 27, 2015 · Completed: Apr 11, 2019
7 conditions
2 sponsors
1 location
NCT02287558
Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
PHASE1
Completed
9 participants
Started: Jan 27, 2015 · Completed: Jun 1, 2019
2 conditions
1 sponsor
1 location
NCT03720119
Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®
N/A
Completed
78 participants
Started: Jan 27, 2015 · Completed: Mar 5, 2018
1 condition
1 sponsor
2 locations
NCT02773225
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)
PHASE2/PHASE3
Completed
93 participants
Started: Jan 27, 2015 · Completed: Jan 30, 2025
1 condition
1 sponsor
1 location
NCT02289157
Negative Pressure Wound Therapy in Cesarean Section
NA
Completed
441 participants
Started: Jan 27, 2015 · Completed: Oct 21, 2016
1 condition
2 sponsors
1 location
NCT02301156
Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)
PHASE3
Completed
126 participants
Started: Jan 27, 2015 · Completed: Apr 1, 2020
1 condition
1 sponsor
88 locations
NCT02377960
Check and Support -Enhancing the Treatment of Hypertension in Outpatient Care, a Multicenter Study
NA
Completed
119 participants
Started: Jan 27, 2015 · Completed: Mar 6, 2018
5 conditions
6 sponsors
6 locations
NCT02145416
ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy
N/A
Completed
29 participants
Started: Jan 27, 2015 · Completed: Apr 12, 2018
1 condition
2 sponsors
1 location
NCT02804776
PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery
PHASE2
Completed
15 participants
Started: Jan 27, 2015 · Completed: Feb 21, 2018
1 condition
1 sponsor
1 location
NCT02380612
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
NA
Completed
30 participants
Started: Jan 26, 2015 · Completed: Feb 1, 2017
1 condition
3 sponsors
7 locations
NCT02345226
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults
PHASE3
Completed
881 participants
Started: Jan 26, 2015 · Completed: Jan 2, 2019
1 condition
1 sponsor
117 locations
NCT02345252
Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)
PHASE3
Completed
632 participants
Started: Jan 26, 2015 · Completed: Jan 9, 2019
1 condition
1 sponsor
117 locations
NCT02278250
First in Human Study of M4344 in Participants With Advanced Solid Tumors
PHASE1
Completed
97 participants
Started: Jan 26, 2015 · Completed: Sep 24, 2021
2 conditions
2 sponsors
16 locations
NCT03163056
Smoking Cessation Treatment for Depressed Smokers
NA
Completed
180 participants
Started: Jan 26, 2015 · Completed: Jul 31, 2019
1 condition
1 sponsor
1 location
NCT02864186
The Benefits of the Use of a Support Bra in Women Undergoing Coronary Artery By-Pass Graft Surgery
NA
Completed
190 participants
Started: Jan 26, 2015 · Completed: Aug 30, 2018
3 conditions
1 sponsor
1 location
Previous
1
More pages
3130
3131
3132
3133
3134
3135
3136
More pages
6093
Next